When will Idelalisib Tablet be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Idelalisib Tablet changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Idelalisib Tablet

Category: Oncology

Not specified 2

FDA status: To Be Discontinued · Last FDA update: Apr 7, 2026 · First posted: Apr 7, 2026 · 1 manufacturers, 2 listed presentations

As of Apr 7, 2026, the FDA lists Idelalisib Tablet as being discontinued. Of 2 manufacturer presentations, 2 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Idelalisib Tablet is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Zydelig, Tablet, 100 mg (NDC 61958-1701-1) NDC 61958-1701-1	Gilead Sciences, Inc.	Not specified	Discontinuation in the manufacturing of the drug
Zydelig, Tablet, 150 mg (NDC 61958-1702-1) NDC 61958-1702-1	Gilead Sciences, Inc.	Not specified	Discontinuation in the manufacturing of the drug

Related medications in shortage

Other Oncology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Idelalisib Tablet (FDA data as of Apr 7, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Idelalisib Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Idelalisib Tablet.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/idelalisib-tablet.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).